Clinical Trials on Chronic Obstructive Pulmonary Disease (COPD)
Total 48486 results
-
Beijing Chao Yang HospitalUnknownCOPD(Chronic Obstructive Pulmonary Disease)China
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)Spain, Germany, Estonia, Hungary, Belgium, Czech Republic, Norway, Korea, Republic of, Lithuania
-
Minneapolis Veterans Affairs Medical CenterCompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
NovartisCompletedChronic Obstructive Pulmonary Disease (COPD)France, Germany, Belgium, Spain, Turkey, Italy, Canada, Australia
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic Obstructive | Chronic Obstructive Pulmonary Disease (COPD)Germany
-
NovartisCompletedChronic Obstructive Pulmonary Disease (COPD)United States, Spain, Turkey, France, Netherlands, Germany
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease | COPD | Moderate to Very Severe COPDUnited States, Canada
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease COPDChina
-
Pearl Therapeutics, Inc.CompletedCOPD, Chronic Obstructive Pulmonary DiseaseBelgium
-
Neutec Ar-Ge San ve Tic A.ŞActive, not recruiting
-
Mylan Pharma UK Ltd.Completed
-
Strados Labs, Inc.WithdrawnChronic Obstructive Pulmonary Disease (COPD)United States
-
Pulmatrix Inc.CompletedChronic Obstructive Pulmonary Disease (COPD)United Kingdom
-
Mylan Inc.Theravance BiopharmaCompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
Mylan Inc.Theravance BiopharmaCompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
Mylan Inc.Theravance BiopharmaCompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
Chiesi Farmaceutici S.p.A.CompletedCOPD (Chronic Obstructive Pulmonary Disease)China, Korea, Republic of, Taiwan
-
Hannover Medical SchoolCAPNETZ StiftungCompletedChronic Obstructive Pulmonary Disease (COPD)Germany
-
University of AarhusCompletedChronic Obstructive Pulmonary Disease, COPDDenmark
-
Barcelona Institute for Global HealthKU Leuven; University Medical Center Groningen; University of Athens; University... and other collaboratorsCompletedChronic Obstructive Pulmonary Disease (COPD)Netherlands, Greece, Belgium, United Kingdom
-
Novartis PharmaceuticalsWithdrawnChronic Obstructive Pulmonary Disease (COPD)
-
Novartis PharmaceuticalsWithdrawnChronic Obstructive Pulmonary Disease (COPD)
-
Memorial Hospital of Rhode IslandNational Heart, Lung, and Blood Institute (NHLBI)CompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
Norwegian University of Science and TechnologyCompletedChronic Obstructive Pulmonary Disease (COPD)Norway
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)Brazil
-
AstraZenecaMitsubishi Tanabe Pharma CorporationCompletedChronic Obstructive Pulmonary Disease (COPD)Japan
-
University of PennsylvaniaTerminatedChronic Obstructive Pulmonary Disease (COPD)United States
-
Chest Hospital, Ministry of Health and Welfare,...CompletedChronic Obstructive Pulmonary Disease (COPD)Taiwan
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)China, Philippines, Korea, Republic of, India
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Romania, Ukraine, Denmark, Netherlands, Canada
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)Japan
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)United States, Colombia, Argentina, Germany, Spain, Turkey, Guatemala, Mexico, Australia, Denmark, South Africa, Philippines
-
NovartisCompletedChronic Obstructive Pulmonary Disease (COPD)Spain, Germany, South Africa, Australia, Poland, New Zealand, Netherlands
-
University of Sao PauloCompletedChronic Obstructive Pulmonary Disease (COPD)Brazil
-
King's College Hospital NHS TrustUniversity of BrightonCompletedChronic Obstructive Pulmonary Disease (COPD)United Kingdom
-
University of Nove de JulhoCompletedChronic Obstructive Pulmonary Disease (COPDBrazil
-
Mylan Inc.Theravance BiopharmaCompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
University Hospital, GhentGlaxoSmithKline; University GhentCompletedChronic Obstructive Pulmonary Disease (COPD)Belgium
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease COPDUnited States, Netherlands, Argentina, South Africa, Chile, Peru
-
Laval UniversityMaltais, Francois, M.D.; Saey, Didier, M.D.CompletedChronic Obstructive Pulmonary Disease (COPD)Canada
-
Sunovion Respiratory Development Inc.CompletedChronic Obstructive Pulmonary Disease (COPD)United States, Czechia, Hungary, Russian Federation
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Germany, Czech Republic, France, Hungary, Italy, Peru, Poland, Russian Federation, South Africa, Spain, Ukraine
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Austria, Belgium, Canada, France, Germany, Italy, Netherlands, South Africa, Spain, United Kingdom
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Germany, Spain, United States, Canada, India, Italy, Poland, South Africa
-
AstraZenecaMitsubishi Tanabe Pharma CorporationCompletedChronic Obstructive Pulmonary Disease (COPD)Japan
-
Nuvaira, Inc.CompletedChronic Obstructive Pulmonary Disease (COPD)Netherlands, South Africa
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)Colombia, India, Korea, Republic of, Poland, Croatia, Estonia, Hungary, United Kingdom, Israel, Latvia, Turkey, Argentina, Panama, Mexico, Russian Federation, Serbia, Slovenia
-
University Medical Center GroningenTerminatedChronic Obstructive Pulmonary Disease (COPD)Netherlands
-
Air Liquide Santé InternationalITEC Services; Lincoln Medical and Mental Health CenterCompletedChronic Obstructive Pulmonary Disease (COPD)France, Spain, Germany, Italy
-
Aveiro UniversityFundação para a Ciência e a TecnologiaCompletedChronic Obstructive Pulmonary Disease (COPD)Portugal